These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36319945)

  • 1. Determining What Represents Value in the Treatment of Refractory or Unexplained Chronic Cough from the Perspective of Key Stakeholders in Spain Using Multi-Criteria Decision Analysis.
    Domingo C; Fernandez M; Garin N; Milara J; Moran I; Muerza I; Pacheco A; Teruel C; Bentley R; Subiran R; Gil A
    Appl Health Econ Health Policy; 2023 Jan; 21(1):119-130. PubMed ID: 36319945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-reported experiences with refractory or unexplained chronic cough: a qualitative analysis.
    Bali V; Schelfhout J; Sher MR; Tripathi Peters A; Patel GB; Mayorga M; Goss D; Romano CD
    Ther Adv Respir Dis; 2024; 18():17534666241236025. PubMed ID: 38501735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA).
    Falip M; López González FJ; Martín-Herranz I; Merino-Bohórquez V; Montoya J; Rey Gómez-Serranillos I; Rodriguez Uranga JJ; Ruiz E; Sancho-López A; Trillo Mata JL; Antoni Vallès J; Álvarez-Barón E; Sabaniego J; Subías-Labazuy S; Gil A
    Epilepsy Behav; 2023 Aug; 145():109350. PubMed ID: 37480633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and Management of Patients with Refractory or Unexplained Chronic Cough in Outpatient Hospital Clinics in Spain: A Retrospective Multicenter Study.
    Dávila I; Puente L; Quirce S; Arismendi E; Díaz-Palacios M; Pereira-Vega A; de Diego A; Rodriguez-Hermosa JL; Cea-Calvo L; Sánchez-Jareño M; López-Cotarelo P; Domingo C
    Lung; 2023 Jun; 201(3):275-286. PubMed ID: 37160771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying key unmet needs and value drivers in the treatment of focal-onset seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through Multi-Criteria Decision Analysis (MCDA).
    Villanueva V; Carreño M; Gil-Nagel A; Serrano-Castro PJ; Serratosa JM; Toledo M; Álvarez-Barón E; Gil A; Subías-Labazuy S
    Epilepsy Behav; 2021 Sep; 122():108222. PubMed ID: 34371462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Speech and language therapy for management of chronic cough.
    Slinger C; Mehdi SB; Milan SJ; Dodd S; Matthews J; Vyas A; Marsden PA
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD013067. PubMed ID: 31335963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Content validity of the Leicester Cough Questionnaire in adults with refractory or unexplained chronic cough: a qualitative interview study.
    Martin Nguyen A; La Rosa C; Cornell AG; Sher MR; Bernstein JA; Birring SS; DeMuro Romano C; Mayorga M; Milien M; Ervin C
    Ther Adv Respir Dis; 2024; 18():17534666241274261. PubMed ID: 39235438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient satisfaction with the management of refractory and unexplained chronic cough in Canada: Results from a national survey.
    Khan S; Brister D; Abraham T; Laventure S; Sahakian S; Juliá B; Satia I
    PLoS One; 2024; 19(8):e0308275. PubMed ID: 39088459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase 3, randomized, double-blind, clinical study to evaluate the long-term safety and efficacy of gefapixant in Japanese adult participants with refractory or unexplained chronic cough.
    Niimi A; Sagara H; Kikuchi M; Arano I; Sato A; Shirakawa M; La Rosa C; Muccino D
    Allergol Int; 2022 Oct; 71(4):498-504. PubMed ID: 35752582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A register-based study: cough - a frequent phenomenon in the adult population.
    Backer V; Porsborg A; Hansen V; Skjold T; Schmid JM; Kehlet M; Torp-Pedersen C; Aasbjerg K
    BMC Pulm Med; 2022 Nov; 22(1):426. PubMed ID: 36401236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leicester Cough Questionnaire validation and clinically important thresholds for change in refractory or unexplained chronic cough.
    Nguyen AM; Schelfhout J; Muccino D; Bacci ED; La Rosa C; Vernon M; Birring SS
    Ther Adv Respir Dis; 2022; 16():17534666221099737. PubMed ID: 35614875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding physician's knowledge and perception of chronic cough in Switzerland.
    Leuppi JD; Guggisberg P; Koch D; Favre-Bulle A; Fabiani M; Heinz S; Zeller A
    Curr Med Res Opin; 2022 Aug; 38(8):1459-1466. PubMed ID: 35369836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of Disease Associated with Refractory and Unexplained Chronic Cough in Canada: Results from a National Survey.
    Brister D; Khan S; Abraham T; Laventure S; Sahakian S; Juliá B; Satia I
    Lung; 2024 Aug; 202(4):415-424. PubMed ID: 38867086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.
    Gil-Nagel A; Falip M; Sánchez-Carpintero R; Abad-Sazatornil MR; Poveda JL; Aibar JÁ; Cardenal-Muñoz E; Aras LM; Sánchez R; Sancho-López A; Trillo-Mata JL; Torrejón M; Gil A
    Epilepsy Behav; 2022 Jul; 132():108711. PubMed ID: 35588562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic cough.
    Dicpinigaitis PV; Birring SS; Blaiss M; McGarvey LP; Morice AH; Pavord ID; Satia I; Smith JA; La Rosa C; Li Q; Nguyen AM; Schelfhout J; Tzontcheva A; Muccino D
    Ann Allergy Asthma Immunol; 2023 Jan; 130(1):60-66. PubMed ID: 35569802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An observational study to understand burden and cost of care in adults diagnosed with refractory chronic cough (RCC) or unexplained chronic cough (UCC).
    Smith JA; Stein N; Migas S; Bokowski S; Williams C; Baker P; New J; Schelfhout J; Fonseca E; Langerman H
    Respir Res; 2024 Jul; 25(1):265. PubMed ID: 38965601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic literature review of treatments used for refractory or unexplained chronic cough in adults.
    Bali V; Kardos P; Page C; Rogliani P; Calzetta L; Adriano A; Byrne A; Adeyemi A; Frederickson A; Schelfhout J
    Ann Thorac Med; 2024; 19(1):56-73. PubMed ID: 38444993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining the value contribution of selexipag for the treatment of pulmonary arterial hypertension (PAH) in Spain using reflective multi-criteria decision analysis (MCDA).
    Jiménez A; Ais A; Beaudet A; Gil A
    Orphanet J Rare Dis; 2018 Dec; 13(1):220. PubMed ID: 30526673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative measurement properties and score interpretation of the Cough Severity Diary in patients with chronic cough.
    Martin Nguyen A; Bacci E; Dicpinigaitis P; Vernon M
    Ther Adv Respir Dis; 2020; 14():1753466620915155. PubMed ID: 32345170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Insights Into Refractory Chronic Cough and Unexplained Chronic Cough: A 6-Year Ambispective Cohort Study.
    Zhang M; Morice AH; Si F; Zhang L; Chen Q; Wang S; Zhu Y; Xu X; Yu L; Qiu Z
    Allergy Asthma Immunol Res; 2023 Nov; 15(6):795-811. PubMed ID: 37957796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.